Latest Articles
Richter signs endometriosis antibody deal - FemTech World
Richter signs endometriosis antibody deal FemTech World
Published: Feb. 19, 2026, 2:03 p.m.
Japanese pharmas team up on AI-led gynaecology drug research - FemTech World
Japanese pharmas team up on AI-led gynaecology drug research FemTech World
Published: Feb. 19, 2026, 1:03 p.m.
Endometriosis-sufferer wins landmark tribunal case on workplace discrimination - FemTech World
Endometriosis-sufferer wins landmark tribunal case on workplace discrimination FemTech World
Published: Feb. 19, 2026, 9:02 a.m.
Body fat percentage associated with endometriosis severity in cross-sectional analysis - Contemporary OB/GYN
Body fat percentage associated with endometriosis severity in cross-sectional analysis Contemporary OB/GYN
Published: Feb. 18, 2026, 8:38 p.m.
Sensei Biotherapeutics Announces Acquisition of Faeth Therapeutics and $200 Million Concurrent Private Placement - PharmiWeb.com
Sensei Biotherapeutics Announces Acquisition of Faeth Therapeutics and $200 Million Concurrent Private Placement PharmiWeb.com
Published: Feb. 18, 2026, 4:05 p.m.
Sensei Biotherapeutics Acquires Faeth Therapeutics, Raises $200M to Advance Multi-Node Cancer Therapy for Endometrial and Breast Cancer - Femtech Insider
Sensei Biotherapeutics Acquires Faeth Therapeutics, Raises $200M to Advance Multi-Node Cancer Therapy for Endometrial and Breast Cancer Femtech Insider
Published: Feb. 18, 2026, 3:28 p.m.
Sensei Biotherapeutics Acquires Faeth Therapeutics in $200M Deal, Advancing Multi-Node Cancer Therapy for Endometrial and Breast Cancer - Femtech Insider
Sensei Biotherapeutics Acquires Faeth Therapeutics in $200M Deal, Advancing Multi-Node Cancer Therapy for Endometrial and Breast Cancer Femtech Insider
Published: Feb. 18, 2026, 3:28 p.m.
FimmCyte Partners with Gedeon Richter to Advance Non-Hormonal Endometriosis Treatment - Femtech Insider
FimmCyte Partners with Gedeon Richter to Advance Non-Hormonal Endometriosis Treatment Femtech Insider
Published: Feb. 18, 2026, 3:18 p.m.
Sensei Biotherapeutics Announces Acquisition of Faeth Therapeutics and $200 Million Concurrent Private Placement - The AI Journal
Sensei Biotherapeutics Announces Acquisition of Faeth Therapeutics and $200 Million Concurrent Private Placement The AI Journal
Published: Feb. 18, 2026, 1:25 p.m.
Sensei Biotherapeutics Announces Acquisition of Faeth Therapeutics and $200 Million Concurrent Private Placement - Business Wire
Sensei Biotherapeutics Announces Acquisition of Faeth Therapeutics and $200 Million Concurrent Private Placement Business Wire
Published: Feb. 18, 2026, 1 p.m.
Link copied to clipboard!